Advancedbiotechnology
Next-Generation Sequencing
Overview
Next-generation sequencing parallelizes millions of reactions: Illumina's reversible-terminator bridge amplification reads ~150-300 bp clusters by fluorescent cycles; long-read platforms (PacBio, Oxford Nanopore) read kilobases to megabases. NGS dropped genome cost from 600, enabling cancer profiling, non-invasive prenatal testing, pathogen surveillance, and population genomics.
Learning objectives
- Explain Illumina sequencing-by-synthesis
- Compare short-read vs long-read platforms
- List major NGS applications
- Explain coverage and depth
Illumina chemistry
DNA is fragmented, adapter-ligated, and bridge-amplified into clonal clusters on a flow cell. Cycles add fluorescent reversible terminators (one base per cycle), imaged, then dye cleaved and 3'-OH unblocked. Millions of clusters read in parallel: 150-300 bp reads, ~99.9% accuracy, terabases per run.
Block-then-unblock chemistry lets every cluster add exactly one base per imaged cycle.
Long reads
PacBio SMRT: polymerase watched in real time (HiFi reads: ~99.9% at 10-25 kb). Oxford Nanopore: DNA threaded through protein pores, current changes read bases (megabase reads, portable MinION). Long reads resolve repeats, structural variants, and complete telomere-to-telomere assemblies.
Only long reads could assemble centromeres and segmental duplications: the 2022 complete genome.
Applications
Whole-genome/exome sequencing (rare disease diagnosis: ~40% solve rate), tumor profiling (targeted therapy), liquid biopsy (ctDNA), NIPT (fetal DNA in maternal blood), microbiome 16S/metagenomics, COVID variant surveillance, and UK Biobank-scale population genomics.
Sequencing is cheap; interpreting variants (VUS) is the hard, human-limited step.
Depth and coverage
Depth: how many reads cover each base (30x standard for genomes; 500x+ for rare tumor variants). Breadth: fraction of genome covered. More depth finds rarer variants but costs more: experimental design balances the two.
Depth follows the question: germline vs rare somatic variants.
Key points
- Illumina: reversible terminators on clonal clusters, massively parallel
- Long reads (PacBio/Nanopore) resolve repeats and structural variants
- Applications: rare disease, oncology, NIPT, microbiomes, surveillance
- Depth = reads per base; design balances depth, breadth, cost
Common misconceptions
✓ Truth: Per-base, Sanger still wins (~99.99% vs ~99.9%); NGS wins on scale and consensus accuracy.
✓ Truth: Most variants are benign or VUS; interpretation needs phenotype, family, and functional data.
Practice questions
Q1. Illumina sequencing uses
- Chain termination
- Reversible-terminator sequencing-by-synthesis on clusters
- Pore currents
- Sanger gels
Fluorescent blocked nucleotides, one base per cycle, imaged across millions of clusters.
Q2. Long-read sequencing's main advantage is
- Lower cost per base
- Resolving repeats and structural variants
- Faster
- No DNA needed
Kilobase-megabase reads span repetitive regions short reads cannot.
Q3. In NGS, 'depth' means
- Genome size
- Number of reads covering each base
- Read length
- Cost
30x depth = each base read ~30 times on average.
Click a question to reveal the answer and explanation.
Frequently asked questions
What is ctDNA?
Circulating tumor DNA in blood: enables liquid biopsies for cancer detection and monitoring.
How did NGS help COVID?
Global sequencing tracked variants (Alpha, Delta, Omicron) in near-real time: genomic epidemiology.
What is the $1000 genome status?
Achieved ~2014, now ~$200-600: the NHGRI's goal drove the entire NGS revolution.